-- 標普全球週四發布的數據顯示，日本4月私部門持續擴張，製造業是自波斯灣戰爭以來日本經濟復甦的早期跡象。 標普全球引述其月度調查報告稱，日本4月份綜合採購經理人指數（PMI）初值為52.4，低於3月份的53.0，但仍高於50榮枯分界線。該指數綜合反映了日本製造業和服務業的產出。 標普全球補充道，日本4月製造業PMI初值上升至54.9，高於3月的51.6；服務業PMI初值為51.2，低於上月的53.4。 標普全球表示：“儘管（日本）服務業企業在第二季度初的業務活動和銷售額增長均有所放緩，但製造業在新增訂單穩步增長的推動下，產量實現了12年來最大幅度的增長。” 日本私人企業在4月再次增加了員工人數，但難以滿足訂單需求。 標普全球指出：“與產量和新增訂單的趨勢一致，日本企業在4月份小幅增加了員工人數。總體就業人數已連續兩年半以上保持增長。” “然而，產能壓力依然存在，未完成訂單量連續第五個月增加。” 日本企業管理者也報告稱，4月營運成本上升。 標普全球表示：“受訪企業普遍強調，員工、原材料、燃料和能源價格上漲。而能源價格上漲又與中東局勢和日元疲軟有關。” 中東局勢也讓日本企業經理人4月的樂觀情緒蒙上陰影。 標普全球表示：「4月份，企業對未來產出的信心連續第二個月減弱，整體樂觀情緒降至2020年8月新冠疫情爆發以來的最低水平。儘管日本企業普遍對全球需求狀況的改善抱有希望，但中東戰爭帶來的不確定性和市場動盪抑制了部分企業的預期。” 這份日本PMI初值報告由標普全球根據4月9日至21日期間對400家製造商和400家服務供應商的調查數據編製而成。
Related Articles
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
$HIG
Research
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
$BKR
Research
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.
$WAB